Vitamin E improves fibrinolytic activity in patients with coronary spastic angina

Thrombosis Research
Shinzo MiyamotoHisao Ogawa

Abstract

The fibrinolytic system has a major role as a defense mechanism against thrombus formation. Net fibrinolytic activity in plasma reflects the balance between tissue-type plasminogen activator and plasminogen activator inhibitor (PAI). PAI is the main factor determining overall fibrinolytic activity. We examined the effects of oral administration of vitamin E, an antioxidant, on fibrinolytic activity and oxidative stress in patients with coronary spastic angina. Forty patients with coronary spastic angina were randomly assigned into two treatment groups, either vitamin E group (alpha-tocopherol acetate, 400 mg/day) or placebo group by means of computerized system. PAI activity and thioredoxin, a marker of oxidative stress, levels were measured before and at the end of 1 month treatment. Before treatment, the levels of PAI activity and thioredoxin were increased in patients with coronary spastic angina as compared with control subjects (n=17) (PAI activity levels: 13.6+/-1.4 vs. 7.6+/-2.2 IU/ml, p<0.05, thioredoxin levels: 22.8+/-1.7 vs. 16.0+/-1.4 ng/ml, p<0.05). In patients with coronary spastic angina, administration of vitamin E decreased both PAI activity and thioredoxin levels (PAI activity levels: 14.7+/-1.7 to 7.5+/-1.6 IU...Continue Reading

References

Sep 28, 1978·The New England Journal of Medicine·L D Hillis, E Braunwald
Nov 11, 1989·Nucleic Acids Research·J MimuroD J Luskutoff
Oct 1, 1988·Journal of the American College of Cardiology·K OkumuraK Matsuyama
Feb 1, 1994·British Heart Journal·T MasudaH Yasue
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·C R WhiteB A Freeman
Apr 1, 1996·International Immunology·H NakamuraL A Herzenberg
Jul 1, 1996·Circulation·K MiwaH Inoue
Aug 7, 1997·The New England Journal of Medicine·M N DiazJ F Keaney
Dec 10, 1997·Internal Medicine·H Yasue, K Kugiyama
May 20, 1999·Journal of the American College of Cardiology·J F BeltrameA Maseri
Jul 22, 1999·Diabetes Research and Clinical Practice·J SkrhaJ Hilgertová
Sep 3, 2002·Atherosclerosis·Leonard Kritharides, Roland Stocker

❮ Previous
Next ❯

Citations

May 14, 2005·Antioxidants & Redox Signaling·Hajime Nakamura
May 22, 2007·Antioxidants & Redox Signaling·Yuma HoshinoJunji Yodoi
Sep 30, 2015·Canadian Journal of Physiology and Pharmacology·Thomas F WhayneNilanjana Maulik
May 19, 2006·Journal of Thrombosis and Haemostasis : JTH·Y M PachecoF J G Muriana
Jun 18, 2010·Cardiovascular Therapeutics·Subrata Chakrabarti, Jane E Freedman
Jul 14, 2005·Annual Review of Nutrition·U SinghI Jialal
Aug 18, 2017·Antioxidants & Redox Signaling·Francesco VioliDaniele Pastori
Jun 26, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Makoto ShonoHisao Ogawa
Feb 17, 2009·Biochemistry. Biokhimii︠a︡·E V KalininaA N Saprin
Feb 13, 2007·American Journal of Physiology. Heart and Circulatory Physiology·M Kobayashi-MiuraJ Yodoi
Jul 14, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·Karen L ReedJames M Becker
Mar 15, 2020·International Journal of Molecular Sciences·Clemens GutmannAlberto Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.